TRAX
TRAX
US3371851029
First Tracks Biotherapeutics, I
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2024 2023 Change %
Total Revenue -- --
--
Cost of Revenue -- --
--
Gross Profit -- --
--
181.101.000 118.461.000
52.9%
Operating Income -181.101.000 -118.461.000
52.9%
Pretax Income -163.705.000 -106.150.000
54.2%
Net Income Common Stockholders -163.705.000 -106.150.000
54.2%
-- --
--
-- --
--
ende